Abstract
With the COVID-19 pandemic, there has been an observed increasing incidence of rare autoimmune diseases. In this scenario, rare autoimmune diseases such as scleroderma, or systemic sclerosis (SSc), stand out. The diagnosis of this disease is based on clinical evaluation, accompanied by the detection of specific antibodies for it. However, conventional techniques such as immunohistochemist…